33 results about "Stage specific" patented technology

An array of multi-stage configured cleansing wipe products may include first stage cleansing wipes and second stage cleansing wipes. The first stage cleansing wipes may have a first structure and a first composition selected in view of a first child developmental stage. The second stage cleansing wipes may have a second structure and a second composition selected in view of a second child developmental stage. The first structure and the first composition are different and potentially progressive from first stage to second stage. First stage product packaging may include at least one first stage-specific indicia and second stage product packaging may include at least one second stage-specific indicia. Stages of the array may be communicated and tailored based upon the foods eaten and the manner of eating (such as being fed or self-feeding) of the babies or children in each stage.

One or more processor cores of a multiple-core processing device each can utilize a processing pipeline having a plurality of execution units (e.g., integer execution units or floating point units) that together share a pre-execution front-end having instruction fetch, decode and dispatch resources. Further, one or more of the processor cores each can implement dispatch resources configured to dispatch multiple instructions in parallel to multiple corresponding execution units via separate dispatch buses. The dispatch resources further can opportunistically decode and dispatch instruction operations from multiple threads in parallel so as to increase the dispatch bandwidth. Moreover, some or all of the stages of the processing pipelines of one or more of the processor cores can be configured to implement independent thread selection for the corresponding stage.

A disposable absorbent article is provided. The article comprises one or more disposable absorbent articles having a configuration corresponding to a wearer's stage of development, the disposable absorbent articles being enclosed in a package; a brand indicator disposed on the package; a line-up indicator disposed on the package, the line-up indicator including visual indicia and narrative indicia; and a stage specific indicator disposed on the package. The line-up indicator and stage specific indicator associate the absorbent article configuration with a corresponding stage of development, the association enabling a consumer to identify the appropriate absorbent article configuration for a wearer. An array of disposable absorbent article configurations is also provided.

An apparatus and method for non-destructively diagnosing crop growth using terahertz waves are provided. The apparatus includes an information extractor configured to extract status information on a crop from information on an image of the crop taken using terahertz waves, a database configured to store growth-stage-specific information on the crop, and a status determiner configured to compare the status information on the crop extracted by the information extractor with the growth-stage-specific information stored in the database, and determine the degree of growth of the crop.

A method for the identification of treatments and preventative agents for brain aging, subjective cognitive impairment (SCI), mild cognitive impairment (MCI), Alzheimer's disease (AD) and other degenerative dementias, the method including (a) the identification of the diagnosis and stage of the subject, (b) the identification of the duration of the stage of the condition and/or disorder, (c) the identification of prognostic markers based upon a formula incorporating the duration of the condition and/or stage, (d) the prospective separation of prognostic subgroups based upon outcome wherein the outcome is defined in these conditions as progression to a subsequent stage or stages, (e) the employment of a putative prognostic marker for an appropriate period of time, based upon the formula incorporating the duration of the condition and/or stage, (f) the application of in vivo, methodology specific techniques, in conjunction with stage specific prognostic subgroups, for the appropriate time period, for the identification, prospectively, of useful markers, (g) the employment of these markers to identify useful therapeutic agents for prevention and treatment.

Differentiation of human pluripotent stem cells, such as human embryonic stem cells (hESC), into hepatocytes by in vitro methods is disclosed. The pluripotent stem cells are cultured in conditioned medium from the hepatocarcinoma cell line, HepG2. Specific growth factors and defined media may also be added to the medium for stage specific differentiation of the derived hepatocytes. Hepatocytes differentiated from human pluripotent stem cells may be characterized by fluorescence activated cell sorting (FACS), immunofluorescence analysis (IF), real time polymerase reaction (RT-PCR), and functional assays. The methods disclosed herein are able to differentiate high percentages of hepatocytes from human pluripotent stem cells using the disclosed methods. These differentiated cells may exhibit polygonal shape morphology, typical of hepatocytes, and may express hepatocyte specific genes. The differentiated cells may also be positive for definitive endoderm markers and hepatic markers.

The invention provides a PMS (phased-mission system) reliability layering modeling method based on a failure mechanism comprehensive damage accumulation rule. The method comprises the following steps:S1, clarifying all the missions needing to be executed and the specific phases of each mission, analyzing component parts of the system under each mission and phase, and clarifying a damage accumulation mode between the key failure mechanism of each part in each mission and phase and the failure mechanism; S2, establishing a BDD model of a system failure mechanism layer according to the main failure mechanism of each working part as well as the type of each failure mechanism and the system structure; S3, establishing a BDD model of a system phase layer by utilizing the BDD model of the systemfailure mechanism layer obtained in the step S2; S4, further establishing a BDD model of a system mission layer for the phased-mission system; and S5, evaluating a reliability function when the phased-mission system executes the mission series. The models of all levels are combined and an integrated method is provided for reliability modeling of the phased-mission system.

The present invention relates to endogenous cardiac stem-progenitor cells (eCSCs). Provided herein are c-kitpos CD166pos eCSCs that are negative for the hematopoietic marker, CD45 and the mast cell marker, Tryptase. These single cell derived eCSCs can differentiate into a variety of specific cell types corresponding to the derivatives of the three germ layers. Also provided herein is a stage-specific TGF-P-Family/Wnt-Inhibitor cocktail for modulating in vitro myogenic specification and maturation of c-kitpos eCSCs. Also provided herein are methods of modulating eCSCs clonal expansion and differentiation. Also provided herein are screening assays for small organic molecules that modulate early cardiomyogenic progenitor cells. The invention further relates to the use of these modulated cells in prophylactic and therapeutic methods, including in pharmaceutical compositions of such cells, growth factors and/or small organic compounds. Finally, the invention relates to the use of such differentiated cells in transplantation and medical treatments.

An optical traffic signal column including stacked levels fixed to one another by rotation. The base of each level includes, distributed along its periphery, oblong passages and fixed connectors. The conductors include rods each having two ends angularly offset from one another, and including a common conducting rod and a stage-specific conducting rod. The connector rods are identical and respectively fix the bottom of a conducting rod of the relevant level and the top of the respective conducting rod of an adjacent level, the angular offset between the two fixing points corresponding to that of ends of the conducting rods. The conducting rods are mutually arranged and mounted to effect, from one level to the next level, an essentially identical angular position of the common conducting rods and an angular offset of the stage-specific conducting rods.

The training management server 3 and the site management server 6 of the content presentation system 1 that presents a training content, when predetermined information that can be an accident occurrence factor in the on-site work of the work target device from a predetermined three-dimensional body motion of the trainee R1 or the model worker R2, adjust the evaluation criterion information on the work operation in the specific stage or other stage of the work procedure of the on-site work related to the information. At that time, the training content is updated so as to increase a probability of occurrence of a simulated accident with respect to the work operation in the specific stage or other stage during the simulated work, and impress the trainee R1 with the occurrence of the accident at occurrence of the simulated accident.

Human pluripotent stem cells (hPSCs) have dual value as microphysiological laboratory models and regenerative therapeutics. hPSCs are epithelial cells, but the extent to which hPSCs and descendant epithelia can reconstitute lineage-specific functions remains poorly understood. Here the Inventors show that hPSCs in three-dimensional cultures and their differentiated descendants can functionally recapitulate tissue-specific epithelial morphogenesis, physiology, and disease.

A developing speed estimation apparatus includes: bibliographic database integrating heterogeneous resources; feature-set creation module calculating feature values of predefined features by searching the bibliographic database, and creating a feature-set of each technology using the feature values, for technologies on technology lifecycle; answer feature-set creation module calculating common feature values of feature sets of technologies belonging to the same stage in the technology lifecycle and creating answer feature-set of each stage; year-specific stage determination module that, if specific technology is inputted, acquires feature-related information for predetermined features by searching the bibliographic database for the specific technology, creates year-specific feature-set using the feature-related information, and determines year-specific stage of the specific technology by comparing the year-specific feature-set with the answer feature-set; and developing-speed estimation module estimating the developing speed of the specific technology using the year-specific stage.

The invention discloses a method for picking a color of an adjustment interface of a special effect monitoring instrument. The method is used for picking the color in nonlinear editing and cutting software and video and audio later-stage specific processing and synthesis software. The technical problem is that an image is displayed on the special effect monitoring instrument, and original color information of an input special effect image is acquired at the same time. In order to solve the technical problem, bottom layer node information, current frame information and output pin information acquired according to input pin information are acquired by extracting image information on a special effect node; a topology relation of connection among nodes is finally established; and information of an input image is acquired. According to the method, the information of the input image of the current special effect plugin is acquired according to the connection relation of the nodes in a whole video special effect processing process, so that a color value of an appointed position can be acquired accurately; and furthermore, due to the mode, the image information in an appointed region on the adjustment interface of the special effect monitoring instrument can be acquired.

Methods and compositions are presented in which catechin-containing compositions have statistically significant and strong therapeutic effect in the treatment of LUTS wherein such compositions are stage-specifically administered to a patient diagnosed with HG-PIN and optional coexistent BPH.

The invention relates to the technical field of electronic finance, and discloses a fraudulent application judging method and device, and a fraudulent application information collection method and device. The judging method comprises that a first server receives an application request of a user, wherein a first user identifier and a first terminal identifier are contained in the application request; the first server determines whether the first terminal identifier uniquely corresponds to the first user identifier or not from first comparison relationships between the terminal identifiers and user identifiers according to the first terminal identifier; and the first server refuses the application request if the first terminal identifier corresponds to more than one user identifier. The method and the device are used for determining the user with a fraudulent behavior in an application stage specific to the condition that the user steals the identity information of others when the application is carried out.